125 related articles for article (PubMed ID: 15745821)
1. Carbonic anhydrase inhibitors. Interaction of isozymes I, II, IV, V, and IX with organic phosphates and phosphonates.
Winum JY; Innocenti A; Gagnard V; Montero JL; Scozzafava A; Vullo D; Supuran CT
Bioorg Med Chem Lett; 2005 Mar; 15(6):1683-6. PubMed ID: 15745821
[TBL] [Abstract][Full Text] [Related]
2. Carbonic anhydrase inhibitors. Interaction of isozymes I, II, IV, V, and IX with phosphates, carbamoyl phosphate, and the phosphonate antiviral drug foscarnet.
Rusconi S; Innocenti A; Vullo D; Mastrolorenzo A; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2004 Dec; 14(23):5763-7. PubMed ID: 15501037
[TBL] [Abstract][Full Text] [Related]
3. Carbonic anhydrase inhibitors: inhibition of the membrane-bound human isozyme IV with anions.
Innocenti A; Firnges MA; Antel J; Wurl M; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2004 Dec; 14(23):5769-73. PubMed ID: 15501038
[TBL] [Abstract][Full Text] [Related]
4. Carbonic anhydrase inhibitors: inhibition of human cytosolic isozymes I and II and tumor-associated isozymes IX and XII with S-substituted 4-chloro-2-mercapto-5-methyl-benzenesulfonamides.
Saczewski F; Innocenti A; Sławiński J; Kornicka A; Brzozowski Z; Pomarnacka E; Scozzafava A; Temperini C; Supuran CT
Bioorg Med Chem; 2008 Apr; 16(7):3933-40. PubMed ID: 18242998
[TBL] [Abstract][Full Text] [Related]
5. Carbonic anhydrase inhibitors: 2-substituted-1,3,4-thiadiazole-5-sulfamides act as powerful and selective inhibitors of the mitochondrial isozymes VA and VB over the cytosolic and membrane-associated carbonic anhydrases I, II and IV.
Smaine FZ; Pacchiano F; Rami M; Barragan-Montero V; Vullo D; Scozzafava A; Winum JY; Supuran CT
Bioorg Med Chem Lett; 2008 Dec; 18(24):6332-5. PubMed ID: 18990571
[TBL] [Abstract][Full Text] [Related]
6. Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isozyme VII with aromatic and heterocyclic sulfonamides.
Vullo D; Voipio J; Innocenti A; Rivera C; Ranki H; Scozzafava A; Kaila K; Supuran CT
Bioorg Med Chem Lett; 2005 Feb; 15(4):971-6. PubMed ID: 15686895
[TBL] [Abstract][Full Text] [Related]
7. Carbonic anhydrase inhibitors. Inhibition of isozymes I, II, IV, V and IX with complex fluorides, chlorides and cyanides.
Innocenti A; Antel J; Wurl M; Vullo D; Firnges MA; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2005 Apr; 15(7):1909-13. PubMed ID: 15780631
[TBL] [Abstract][Full Text] [Related]
8. Carbonic anhydrase inhibitors. Inhibition of isozymes I, II, IV, V, and IX with anions isosteric and isoelectronic with sulfate, nitrate, and carbonate.
Innocenti A; Vullo D; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2005 Feb; 15(3):567-71. PubMed ID: 15664814
[TBL] [Abstract][Full Text] [Related]
9. Carbonic anhydrase inhibitors. Interaction of isozymes I, II, IV, V, and IX with carboxylates.
Innocenti A; Vullo D; Scozzafava A; Casey JR; Supuran C
Bioorg Med Chem Lett; 2005 Feb; 15(3):573-8. PubMed ID: 15664815
[TBL] [Abstract][Full Text] [Related]
10. Carbonic anhydrase inhibitors. Regioselective synthesis of novel series 1-substituted 1,4-dihydro-4-oxo-3-pyridinesulfonamides and their inhibition of the human cytosolic isozymes I and II and transmembrane cancer-associated isozymes IX and XII.
Brzozowski Z; Sławiński J; Vullo D; Supuran CT
Eur J Med Chem; 2012 Oct; 56():282-91. PubMed ID: 22910138
[TBL] [Abstract][Full Text] [Related]
11. Carbonic anhydrase inhibitors. Inhibition of the membrane-bound human and bovine isozymes IV with sulfonamides.
Innocenti A; Firnges MA; Antel J; Wurl M; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2005 Feb; 15(4):1149-54. PubMed ID: 15686931
[TBL] [Abstract][Full Text] [Related]
12. Carbonic anhydrase inhibitors. Synthesis, molecular structures, and inhibition of the human cytosolic isozymes I and II and transmembrane isozymes IX, XII (cancer-associated) and XIV with novel 3-pyridinesulfonamide derivatives.
Brzozowski Z; Sławiński J; Gdaniec M; Innocenti A; Supuran CT
Eur J Med Chem; 2011 Sep; 46(9):4403-10. PubMed ID: 21820216
[TBL] [Abstract][Full Text] [Related]
13. Carbonic anhydrase inhibitors: inhibition of human cytosolic isozyme II and mitochondrial isozyme V with a series of benzene sulfonamide derivatives.
Innocenti A; Antel J; Wurl M; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2004 Nov; 14(22):5703-7. PubMed ID: 15482952
[TBL] [Abstract][Full Text] [Related]
14. Carbonic anhydrase inhibitors. Inhibition of transmembrane isozymes XII (cancer-associated) and XIV with anions.
Innocenti A; Vullo D; Pastorek J; Scozzafava A; Pastorekova S; Nishimori I; Supuran CT
Bioorg Med Chem Lett; 2007 Mar; 17(6):1532-7. PubMed ID: 17257840
[TBL] [Abstract][Full Text] [Related]
15. Carbonic anhydrase inhibitors. Inhibition of cytosolic isoforms I and II, and extracellular isoforms IV, IX, and XII with sulfamides incorporating sugar moieties.
Colinas PA; Bravo RD; Vullo D; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2007 Sep; 17(18):5086-90. PubMed ID: 17658252
[TBL] [Abstract][Full Text] [Related]
16. Carbonic anhydrase inhibitors. Aromatic/heterocyclic sulfonamides incorporating phenacetyl, pyridylacetyl and thienylacetyl tails act as potent inhibitors of human mitochondrial isoforms VA and VB.
Güzel O; Innocenti A; Scozzafava A; Salman A; Supuran CT
Bioorg Med Chem; 2009 Jul; 17(14):4894-9. PubMed ID: 19539481
[TBL] [Abstract][Full Text] [Related]
17. Carbonic anhydrase inhibitors. Identification of selective inhibitors of the human mitochondrial isozymes VA and VB over the cytosolic isozymes I and II from a natural product-based phenolic library.
Davis RA; Innocenti A; Poulsen SA; Supuran CT
Bioorg Med Chem; 2010 Jan; 18(1):14-8. PubMed ID: 19962903
[TBL] [Abstract][Full Text] [Related]
18. Carbonic anhydrase inhibitors. Inhibition of the transmembrane isozyme XII with sulfonamides-a new target for the design of antitumor and antiglaucoma drugs?
Vullo D; Innocenti A; Nishimori I; Pastorek J; Scozzafava A; Pastoreková S; Supuran CT
Bioorg Med Chem Lett; 2005 Feb; 15(4):963-9. PubMed ID: 15686894
[TBL] [Abstract][Full Text] [Related]
19. Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with fluorine-containing sulfonamides. The first subnanomolar CA IX inhibitor discovered.
Vullo D; Scozzafava A; Pastorekova S; Pastorek J; Supuran CT
Bioorg Med Chem Lett; 2004 May; 14(9):2351-6. PubMed ID: 15081039
[TBL] [Abstract][Full Text] [Related]
20. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides derived from 4-isothiocyanato-benzolamide.
Cecchi A; Winum JY; Innocenti A; Vullo D; Montero JL; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2004 Dec; 14(23):5775-80. PubMed ID: 15501039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
